KOPRAN
Back to All Ratios
|
KOPRAN Last 5 Year Payable days History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Payable days | 97.72 | 81.67 | 108.83 | 90.60 | 100.26 |
What is the latest Payable days ratio of KOPRAN ?
Year | Payable days |
---|---|
Mar2024 | 97.72 |
Mar2023 | 81.67 |
Mar2022 | 108.83 |
Mar2021 | 90.60 |
Mar2020 | 100.26 |
How is Payable days of KOPRAN Trending?
Years | Payable days | % Change | |
---|---|---|---|
Mar2024 | 97.72 | 19.65 | |
Mar2023 | 81.67 | -24.96 | |
Mar2022 | 108.83 | 20.12 | |
Mar2021 | 90.6 | -9.63 | |
Mar2020 | 100.26 | - |
Other Financial Ratios of KOPRAN
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Payable days ratio of peers of KOPRAN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KOPRAN | ₹1,477.8 Cr | 5.4% | 3.7% | 37.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹434,604.0 Cr | 0.1% | -4% | 52.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,639.0 Cr | 0.7% | -0% | 70.9% | Stock Analytics | |
CIPLA | ₹128,549.0 Cr | 0.5% | -1.7% | 29.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,956.0 Cr | 1.1% | -2.6% | 19.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,468.9 Cr | -3.6% | -8.4% | 62.9% | Stock Analytics |
KOPRAN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KOPRAN | 5.4% |
3.7% |
37.4% |
SENSEX | -0.3% |
-2.4% |
22.4% |
You may also like the below Video Courses